Biocon drug for COVID 19 ALZUMAb® (Itolizumab) to cost Rs 7,950 per vial
Biocon Ltd, an innovation-led global biopharmaceuticals company, presenting its key insights into the results of the Itolizumab for treating patients […]
Say something
Itolizumab to save many COVID 19 patients, asserts Biocon Ltd
After India’s drug regulator approved Itolizumab, for “restricted emergency use” to treat COVID-19 patients with moderate to severe acute respiratory […]
DCGI gives nod for restricted emergency use for Itolizumab in COVID-19 treatment
India’s drug regulator has approved Itolizumab, a medicine used to cure severe plaque psoriasis for “restricted emergency use” to treat […]
-
-
Flipkart Health+ App Launched
06-04-2022
